Adriamycin transport and sensitivity in fatty acid-modified leukemia cells.
The membrane phospholipids of L1210 murine leukemia cells were modified by supplementing the growth medium with micromolar concentrations of polyunsaturated or monounsaturated fatty acids. This procedure results in enrichment of cellular phospholipids by the supplemented fatty acid. Enrichment with polyunsaturated fatty acids resulted in a marked increase in sensitivity to adriamycin as compared to enrichment with monounsaturated fatty acids. The increased cytotoxicity was directly proportional to the extent of unsaturation of the inserted fatty acid, but there was no difference in cells enriched with n-3 compared with n-6 family fatty acids. To explore the mechanism of this observation, we examined whether augmented uptake of the drug might explain the increased cytotoxicity. The uptake of [14C]adriamycin, which was approximately linear at later time points, was only partially temperature dependent and never reached a steady state. Initial uptake at time points prior to 60 s could not be measured due to high and variable rapid membrane adsorption. Cellular accumulation of drug was greater in the docosahexaenoate 22:6-enriched L1210 cells as compared to oleate 18:1-enriched cells and was about 32% greater after 20 min. When L1210 cells were enriched with six fatty acids of variable degrees of unsaturation, the accumulation of adriamycin was directly correlated with the average number of double bonds in the fatty acids contained in cellular phospholipids. There was no difference in efflux of drug from cells pre-loaded with adriamycin. We conclude that the greater accumulation of adriamycin by the polyunsaturated fatty acid-enriched L1210 cells likely explains the increased sensitivity of these cells to adriamycin compared to 18:1-enriched cells.
D000818:Animals; D001692:Biological Transport; D004317:Doxorubicin / Q000378:metabolism* / Q000633:toxicity; D005089:Exocytosis; D005227:Fatty Acids / Q000502:physiology*; D005231:Fatty Acids, Unsaturated / Q000502:physiology*; D007939:Leukemia L1210 / Q000378:metabolism*; D051379:Mice; D010743:Phospholipids / Q000502:physiology*; D013329:Structure-Activity Relationship; D013696:Temperature
D005227:Fatty Acids; D005231:Fatty Acids, Unsaturated; D010743:Phospholipids; D004317:Doxorubicin